Covid-19 Impact on Bulk Drug Market, Global Research Reports 2020-2021
This report covers market size and forecasts of Bulk Drug, including the following market information:
Major competitors identified in this market include Teva, Novartis, Pfizer, Johnson & Johnson, Mylan, North China Pharmaceutical Group, Dr. Reddy’s Laboratories, Roche, Aurobindo pharma, Sun Pharmaceutical Industries, Boehringer Ingelheim GmbH, Bayer, BASF, DSM, Zhejiang Medicine, Biocon, Johnson Matthey, Hisun Pharmacy, Cambrex, Shandong Xinhua Pharmaceutical, Lonza group, Huahai Pharmaceutical, Haerbin Pharmaceutical Group, etc.
Based on the Region:
- Global Bulk Drug Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K MT)
- Global Bulk Drug Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K MT)
- Global Bulk Drug Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K MT)
- Global Bulk Drug Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K MT)
Major competitors identified in this market include Teva, Novartis, Pfizer, Johnson & Johnson, Mylan, North China Pharmaceutical Group, Dr. Reddy’s Laboratories, Roche, Aurobindo pharma, Sun Pharmaceutical Industries, Boehringer Ingelheim GmbH, Bayer, BASF, DSM, Zhejiang Medicine, Biocon, Johnson Matthey, Hisun Pharmacy, Cambrex, Shandong Xinhua Pharmaceutical, Lonza group, Huahai Pharmaceutical, Haerbin Pharmaceutical Group, etc.
Based on the Region:
- Asia-Pacific (China, Japan, South Korea, India and ASEAN)
- North America (US and Canada)
- Europe (Germany, France, UK and Italy)
- Rest of World (Latin America, Middle East & Africa)
- Antibiotics
- Sulpha Drugs
- Vitamins,
- Steroids
- Analgesics
- Others
- Hospitals
- Clinics
- Others
1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Bulk Drug Industry
1.7 COVID-19 Impact: Bulk Drug Market Trends
2 GLOBAL BULK DRUG QUARTERLY MARKET SIZE ANALYSIS
2.1 Bulk Drug Business Impact Assessment - COVID-19
2.1.1 Global Bulk Drug Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.1.2 Global Bulk Drug Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Bulk Drug Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 Global Bulk Drug Quarterly Market Size by Manufacturers, 2019 VS 2020
3.2 Global Bulk Drug Factory Price by Manufacturers
3.3 Location of Key Manufacturers Bulk Drug Manufacturing Factories and Area Served
3.4 Date of Key Manufacturers Enter into Bulk Drug Market
3.5 Key Manufacturers Bulk Drug Product Offered
3.6 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON BULK DRUG SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 Antibiotics
1.4.2 Sulpha Drugs
1.4.3 Vitamins,
1.4.4 Steroids
1.4.5 Analgesics
1.4.6 Others
4.2 By Type, Global Bulk Drug Market Size, 2019-2021
4.2.1 By Type, Global Bulk Drug Market Size by Type, 2020-2021
4.2.2 By Type, Global Bulk Drug Price, 2020-2021
5 IMPACT OF COVID-19 ON BULK DRUG SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 Hospitals
5.5.2 Clinics
5.5.3 Others
5.2 By Application, Global Bulk Drug Market Size, 2019-2021
5.2.1 By Application, Global Bulk Drug Market Size by Application, 2019-2021
5.2.2 By Application, Global Bulk Drug Price, 2020-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 Teva
7.1.1 Teva Business Overview
7.1.2 Teva Bulk Drug Quarterly Production and Revenue, 2020
7.1.3 Teva Bulk Drug Product Introduction
7.1.4 Teva Response to COVID-19 and Related Developments
7.2 Novartis
7.2.1 Novartis Business Overview
7.2.2 Novartis Bulk Drug Quarterly Production and Revenue, 2020
7.2.3 Novartis Bulk Drug Product Introduction
7.2.4 Novartis Response to COVID-19 and Related Developments
7.3 Pfizer
7.3.1 Pfizer Business Overview
7.3.2 Pfizer Bulk Drug Quarterly Production and Revenue, 2020
7.3.3 Pfizer Bulk Drug Product Introduction
7.3.4 Pfizer Response to COVID-19 and Related Developments
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Business Overview
7.4.2 Johnson & Johnson Bulk Drug Quarterly Production and Revenue, 2020
7.4.3 Johnson & Johnson Bulk Drug Product Introduction
7.4.4 Johnson & Johnson Response to COVID-19 and Related Developments
7.5 Mylan
7.5.1 Mylan Business Overview
7.5.2 Mylan Bulk Drug Quarterly Production and Revenue, 2020
7.5.3 Mylan Bulk Drug Product Introduction
7.5.4 Mylan Response to COVID-19 and Related Developments
7.6 North China Pharmaceutical Group
7.6.1 North China Pharmaceutical Group Business Overview
7.6.2 North China Pharmaceutical Group Bulk Drug Quarterly Production and Revenue, 2020
7.6.3 North China Pharmaceutical Group Bulk Drug Product Introduction
7.6.4 North China Pharmaceutical Group Response to COVID-19 and Related Developments
7.7 Dr. Reddy’s Laboratories
7.7.1 Dr. Reddy’s Laboratories Business Overview
7.7.2 Dr. Reddy’s Laboratories Bulk Drug Quarterly Production and Revenue, 2020
7.7.3 Dr. Reddy’s Laboratories Bulk Drug Product Introduction
7.7.4 Dr. Reddy’s Laboratories Response to COVID-19 and Related Developments
7.8 Roche
7.8.1 Roche Business Overview
7.8.2 Roche Bulk Drug Quarterly Production and Revenue, 2020
7.8.3 Roche Bulk Drug Product Introduction
7.8.4 Roche Response to COVID-19 and Related Developments
7.9 Aurobindo pharma
7.9.1 Aurobindo pharma Business Overview
7.9.2 Aurobindo pharma Bulk Drug Quarterly Production and Revenue, 2020
7.9.3 Aurobindo pharma Bulk Drug Product Introduction
7.9.4 Aurobindo pharma Response to COVID-19 and Related Developments
7.10 Sun Pharmaceutical Industries
7.10.1 Sun Pharmaceutical Industries Business Overview
7.10.2 Sun Pharmaceutical Industries Bulk Drug Quarterly Production and Revenue, 2020
7.10.3 Sun Pharmaceutical Industries Bulk Drug Product Introduction
7.10.4 Sun Pharmaceutical Industries Response to COVID-19 and Related Developments
7.11 Boehringer Ingelheim GmbH
7.11.1 Boehringer Ingelheim GmbH Business Overview
7.11.2 Boehringer Ingelheim GmbH Bulk Drug Quarterly Production and Revenue, 2020
7.11.3 Boehringer Ingelheim GmbH Bulk Drug Product Introduction
7.11.4 Boehringer Ingelheim GmbH Response to COVID-19 and Related Developments
7.12 Bayer
7.12.1 Bayer Business Overview
7.12.2 Bayer Bulk Drug Quarterly Production and Revenue, 2020
7.12.3 Bayer Bulk Drug Product Introduction
7.12.4 Bayer Response to COVID-19 and Related Developments
7.13 BASF
7.13.1 BASF Business Overview
7.13.2 BASF Bulk Drug Quarterly Production and Revenue, 2020
7.13.3 BASF Bulk Drug Product Introduction
7.13.4 BASF Response to COVID-19 and Related Developments
7.14 DSM
7.14.1 DSM Business Overview
7.14.2 DSM Bulk Drug Quarterly Production and Revenue, 2020
7.14.3 DSM Bulk Drug Product Introduction
7.14.4 DSM Response to COVID-19 and Related Developments
7.15 Zhejiang Medicine
7.15.1 Zhejiang Medicine Business Overview
7.15.2 Zhejiang Medicine Bulk Drug Quarterly Production and Revenue, 2020
7.15.3 Zhejiang Medicine Bulk Drug Product Introduction
7.15.4 Zhejiang Medicine Response to COVID-19 and Related Developments
7.16 Biocon
7.16.1 Biocon Business Overview
7.16.2 Biocon Bulk Drug Quarterly Production and Revenue, 2020
7.16.3 Biocon Bulk Drug Product Introduction
7.16.4 Biocon Response to COVID-19 and Related Developments
7.17 Johnson Matthey
7.17.1 Johnson Matthey Business Overview
7.17.2 Johnson Matthey Bulk Drug Quarterly Production and Revenue, 2020
7.17.3 Johnson Matthey Bulk Drug Product Introduction
7.17.4 Johnson Matthey Response to COVID-19 and Related Developments
7.18 Hisun Pharmacy
7.18.1 Hisun Pharmacy Business Overview
7.18.2 Hisun Pharmacy Bulk Drug Quarterly Production and Revenue, 2020
7.18.3 Hisun Pharmacy Bulk Drug Product Introduction
7.18.4 Hisun Pharmacy Response to COVID-19 and Related Developments
7.19 Cambrex
7.19.1 Cambrex Business Overview
7.19.2 Cambrex Bulk Drug Quarterly Production and Revenue, 2020
7.19.3 Cambrex Bulk Drug Product Introduction
7.19.4 Cambrex Response to COVID-19 and Related Developments
7.20 Shandong Xinhua Pharmaceutical
7.20.1 Shandong Xinhua Pharmaceutical Business Overview
7.20.2 Shandong Xinhua Pharmaceutical Bulk Drug Quarterly Production and Revenue, 2020
7.20.3 Shandong Xinhua Pharmaceutical Bulk Drug Product Introduction
7.20.4 Shandong Xinhua Pharmaceutical Response to COVID-19 and Related Developments
7.21 Lonza group
7.21.1 Lonza group Business Overview
7.21.2 Lonza group Bulk Drug Quarterly Production and Revenue, 2020
7.21.3 Lonza group Bulk Drug Product Introduction
7.21.4 Lonza group Response to COVID-19 and Related Developments
7.22 Huahai Pharmaceutical
7.22.1 Huahai Pharmaceutical Business Overview
7.22.2 Huahai Pharmaceutical Bulk Drug Quarterly Production and Revenue, 2020
7.22.3 Huahai Pharmaceutical Bulk Drug Product Introduction
7.22.4 Huahai Pharmaceutical Response to COVID-19 and Related Developments
7.23 Haerbin Pharmaceutical Group
7.23.1 Haerbin Pharmaceutical Group Business Overview
7.23.2 Haerbin Pharmaceutical Group Bulk Drug Quarterly Production and Revenue, 2020
7.23.3 Haerbin Pharmaceutical Group Bulk Drug Product Introduction
7.23.4 Haerbin Pharmaceutical Group Response to COVID-19 and Related Developments
8 SUPPLY CHAIN AND SALES CHANNELS ANALYSIS
8.1 Bulk Drug Supply Chain Analysis
8.1.1 Bulk Drug Supply Chain Analysis
8.1.2 Covid-19 Impact on Bulk Drug Supply Chain
8.2 Distribution Channels Analysis
8.2.1 Bulk Drug Distribution Channels
8.2.2 Covid-19 Impact on Bulk Drug Distribution Channels
8.2.3 Bulk Drug Distributors
8.3 Bulk Drug Customers
9 KEY FINDINGS
10 APPENDIX
10.1 About Us
10.2 Disclaimer
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Bulk Drug Industry
1.7 COVID-19 Impact: Bulk Drug Market Trends
2 GLOBAL BULK DRUG QUARTERLY MARKET SIZE ANALYSIS
2.1 Bulk Drug Business Impact Assessment - COVID-19
2.1.1 Global Bulk Drug Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.1.2 Global Bulk Drug Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Bulk Drug Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 Global Bulk Drug Quarterly Market Size by Manufacturers, 2019 VS 2020
3.2 Global Bulk Drug Factory Price by Manufacturers
3.3 Location of Key Manufacturers Bulk Drug Manufacturing Factories and Area Served
3.4 Date of Key Manufacturers Enter into Bulk Drug Market
3.5 Key Manufacturers Bulk Drug Product Offered
3.6 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON BULK DRUG SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 Antibiotics
1.4.2 Sulpha Drugs
1.4.3 Vitamins,
1.4.4 Steroids
1.4.5 Analgesics
1.4.6 Others
4.2 By Type, Global Bulk Drug Market Size, 2019-2021
4.2.1 By Type, Global Bulk Drug Market Size by Type, 2020-2021
4.2.2 By Type, Global Bulk Drug Price, 2020-2021
5 IMPACT OF COVID-19 ON BULK DRUG SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 Hospitals
5.5.2 Clinics
5.5.3 Others
5.2 By Application, Global Bulk Drug Market Size, 2019-2021
5.2.1 By Application, Global Bulk Drug Market Size by Application, 2019-2021
5.2.2 By Application, Global Bulk Drug Price, 2020-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 Teva
7.1.1 Teva Business Overview
7.1.2 Teva Bulk Drug Quarterly Production and Revenue, 2020
7.1.3 Teva Bulk Drug Product Introduction
7.1.4 Teva Response to COVID-19 and Related Developments
7.2 Novartis
7.2.1 Novartis Business Overview
7.2.2 Novartis Bulk Drug Quarterly Production and Revenue, 2020
7.2.3 Novartis Bulk Drug Product Introduction
7.2.4 Novartis Response to COVID-19 and Related Developments
7.3 Pfizer
7.3.1 Pfizer Business Overview
7.3.2 Pfizer Bulk Drug Quarterly Production and Revenue, 2020
7.3.3 Pfizer Bulk Drug Product Introduction
7.3.4 Pfizer Response to COVID-19 and Related Developments
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Business Overview
7.4.2 Johnson & Johnson Bulk Drug Quarterly Production and Revenue, 2020
7.4.3 Johnson & Johnson Bulk Drug Product Introduction
7.4.4 Johnson & Johnson Response to COVID-19 and Related Developments
7.5 Mylan
7.5.1 Mylan Business Overview
7.5.2 Mylan Bulk Drug Quarterly Production and Revenue, 2020
7.5.3 Mylan Bulk Drug Product Introduction
7.5.4 Mylan Response to COVID-19 and Related Developments
7.6 North China Pharmaceutical Group
7.6.1 North China Pharmaceutical Group Business Overview
7.6.2 North China Pharmaceutical Group Bulk Drug Quarterly Production and Revenue, 2020
7.6.3 North China Pharmaceutical Group Bulk Drug Product Introduction
7.6.4 North China Pharmaceutical Group Response to COVID-19 and Related Developments
7.7 Dr. Reddy’s Laboratories
7.7.1 Dr. Reddy’s Laboratories Business Overview
7.7.2 Dr. Reddy’s Laboratories Bulk Drug Quarterly Production and Revenue, 2020
7.7.3 Dr. Reddy’s Laboratories Bulk Drug Product Introduction
7.7.4 Dr. Reddy’s Laboratories Response to COVID-19 and Related Developments
7.8 Roche
7.8.1 Roche Business Overview
7.8.2 Roche Bulk Drug Quarterly Production and Revenue, 2020
7.8.3 Roche Bulk Drug Product Introduction
7.8.4 Roche Response to COVID-19 and Related Developments
7.9 Aurobindo pharma
7.9.1 Aurobindo pharma Business Overview
7.9.2 Aurobindo pharma Bulk Drug Quarterly Production and Revenue, 2020
7.9.3 Aurobindo pharma Bulk Drug Product Introduction
7.9.4 Aurobindo pharma Response to COVID-19 and Related Developments
7.10 Sun Pharmaceutical Industries
7.10.1 Sun Pharmaceutical Industries Business Overview
7.10.2 Sun Pharmaceutical Industries Bulk Drug Quarterly Production and Revenue, 2020
7.10.3 Sun Pharmaceutical Industries Bulk Drug Product Introduction
7.10.4 Sun Pharmaceutical Industries Response to COVID-19 and Related Developments
7.11 Boehringer Ingelheim GmbH
7.11.1 Boehringer Ingelheim GmbH Business Overview
7.11.2 Boehringer Ingelheim GmbH Bulk Drug Quarterly Production and Revenue, 2020
7.11.3 Boehringer Ingelheim GmbH Bulk Drug Product Introduction
7.11.4 Boehringer Ingelheim GmbH Response to COVID-19 and Related Developments
7.12 Bayer
7.12.1 Bayer Business Overview
7.12.2 Bayer Bulk Drug Quarterly Production and Revenue, 2020
7.12.3 Bayer Bulk Drug Product Introduction
7.12.4 Bayer Response to COVID-19 and Related Developments
7.13 BASF
7.13.1 BASF Business Overview
7.13.2 BASF Bulk Drug Quarterly Production and Revenue, 2020
7.13.3 BASF Bulk Drug Product Introduction
7.13.4 BASF Response to COVID-19 and Related Developments
7.14 DSM
7.14.1 DSM Business Overview
7.14.2 DSM Bulk Drug Quarterly Production and Revenue, 2020
7.14.3 DSM Bulk Drug Product Introduction
7.14.4 DSM Response to COVID-19 and Related Developments
7.15 Zhejiang Medicine
7.15.1 Zhejiang Medicine Business Overview
7.15.2 Zhejiang Medicine Bulk Drug Quarterly Production and Revenue, 2020
7.15.3 Zhejiang Medicine Bulk Drug Product Introduction
7.15.4 Zhejiang Medicine Response to COVID-19 and Related Developments
7.16 Biocon
7.16.1 Biocon Business Overview
7.16.2 Biocon Bulk Drug Quarterly Production and Revenue, 2020
7.16.3 Biocon Bulk Drug Product Introduction
7.16.4 Biocon Response to COVID-19 and Related Developments
7.17 Johnson Matthey
7.17.1 Johnson Matthey Business Overview
7.17.2 Johnson Matthey Bulk Drug Quarterly Production and Revenue, 2020
7.17.3 Johnson Matthey Bulk Drug Product Introduction
7.17.4 Johnson Matthey Response to COVID-19 and Related Developments
7.18 Hisun Pharmacy
7.18.1 Hisun Pharmacy Business Overview
7.18.2 Hisun Pharmacy Bulk Drug Quarterly Production and Revenue, 2020
7.18.3 Hisun Pharmacy Bulk Drug Product Introduction
7.18.4 Hisun Pharmacy Response to COVID-19 and Related Developments
7.19 Cambrex
7.19.1 Cambrex Business Overview
7.19.2 Cambrex Bulk Drug Quarterly Production and Revenue, 2020
7.19.3 Cambrex Bulk Drug Product Introduction
7.19.4 Cambrex Response to COVID-19 and Related Developments
7.20 Shandong Xinhua Pharmaceutical
7.20.1 Shandong Xinhua Pharmaceutical Business Overview
7.20.2 Shandong Xinhua Pharmaceutical Bulk Drug Quarterly Production and Revenue, 2020
7.20.3 Shandong Xinhua Pharmaceutical Bulk Drug Product Introduction
7.20.4 Shandong Xinhua Pharmaceutical Response to COVID-19 and Related Developments
7.21 Lonza group
7.21.1 Lonza group Business Overview
7.21.2 Lonza group Bulk Drug Quarterly Production and Revenue, 2020
7.21.3 Lonza group Bulk Drug Product Introduction
7.21.4 Lonza group Response to COVID-19 and Related Developments
7.22 Huahai Pharmaceutical
7.22.1 Huahai Pharmaceutical Business Overview
7.22.2 Huahai Pharmaceutical Bulk Drug Quarterly Production and Revenue, 2020
7.22.3 Huahai Pharmaceutical Bulk Drug Product Introduction
7.22.4 Huahai Pharmaceutical Response to COVID-19 and Related Developments
7.23 Haerbin Pharmaceutical Group
7.23.1 Haerbin Pharmaceutical Group Business Overview
7.23.2 Haerbin Pharmaceutical Group Bulk Drug Quarterly Production and Revenue, 2020
7.23.3 Haerbin Pharmaceutical Group Bulk Drug Product Introduction
7.23.4 Haerbin Pharmaceutical Group Response to COVID-19 and Related Developments
8 SUPPLY CHAIN AND SALES CHANNELS ANALYSIS
8.1 Bulk Drug Supply Chain Analysis
8.1.1 Bulk Drug Supply Chain Analysis
8.1.2 Covid-19 Impact on Bulk Drug Supply Chain
8.2 Distribution Channels Analysis
8.2.1 Bulk Drug Distribution Channels
8.2.2 Covid-19 Impact on Bulk Drug Distribution Channels
8.2.3 Bulk Drug Distributors
8.3 Bulk Drug Customers
9 KEY FINDINGS
10 APPENDIX
10.1 About Us
10.2 Disclaimer
LIST OF TABLES
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Bulk Drug Assessment
Table 9. COVID-19 Impact: Bulk Drug Market Trends
Table 10. COVID-19 Impact Global Bulk Drug Market Size
Table 11. Global Bulk Drug Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (K MT)
Table 12. Global Bulk Drug Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/MT)
Table 13. Global Bulk Drug Quarterly Market Size, 2020 (US$ Million) & (K MT)
Table 14. Global Bulk Drug Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 15. Global Bulk Drug Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (K MT)
Table 16. Global Bulk Drug Market Growth Drivers
Table 17. Global Bulk Drug Market Restraints
Table 18. Global Bulk Drug Market Opportunities
Table 19. Global Bulk Drug Market Challenges
Table 20. Key Manufacturers Bulk Drug Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 21. Top Manufacturers, Bulk Drug Market Size, 2019 (K MT) & (US$ Million)
Table 22. Bulk Drug Factory Price by Manufacturers 2020 (USD/MT)
Table 23. Location of Key Manufacturers Bulk Drug Manufacturing Plants
Table 24. Key Manufacturers Bulk Drug Market Served
Table 25. Date of Key Manufacturers Enter into Bulk Drug Market
Table 26. Key Manufacturers Bulk Drug Product Type
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Bulk Drug Market Size by Type, 2020, (US$ Million)
Table 29. Global Bulk Drug Market Size by Type, 2020 (K MT)
Table 30. Global Bulk Drug Price: by Type, 2020-2021 (USD/MT)
Table 31. Global Bulk Drug Market Size by Application: 2020-2021 (US$ Million)
Table 32. Global Bulk Drug Market Size by Application, 2020-2021 (K MT)
Table 33. Global Bulk Drug Price: by Application, 2020-2021 (USD/MT)
Table 34. Global Bulk Drug Market Size by Region, 2019-2021 (US$ Million)
Table 35. Global Bulk Drug Market Size by Region, 2019-2021 (K MT)
Table 36. By Country, North America Bulk Drug Market Size, 2019-2021 (US$ Million)
Table 37. By Country, North America Bulk Drug Market Size, 2019-2021 (K MT)
Table 38. US Bulk Drug Market Size, 2019-2021 (US$ Million) & (K MT)
Table 39. Canada Bulk Drug Market Size, 2019-2021 (US$ Million) & (K MT)
Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 41. By Country, Europe Bulk Drug Market Size, 2019-2021 (US$ Million)
Table 42. By Country, Europe Bulk Drug Market Size, 2019-2021 (K MT)
Table 43. Germany Bulk Drug Market Size, 2019-2021 (US$ Million) & (K MT)
Table 44. France Bulk Drug Market Size, 2019-2021 (US$ Million) & (K MT)
Table 45. UK Bulk Drug Market Size, 2019-2021 (US$ Million) & (K MT)
Table 46. Italy Bulk Drug Market Size, 2019-2021 (US$ Million) & (K MT)
Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 48. By Region, Asia-Pacific Bulk Drug Market Size, 2019-2021 (US$ Million)
Table 49. By Region, Asia-Pacific Bulk Drug Market Size, 2019-2021 (K MT)
Table 50. China Bulk Drug Market Size, 2019-2021 (US$ Million) & (K MT)
Table 51. Japan Bulk Drug Market Size, 2019-2021 (US$ Million) & (K MT)
Table 52. South Korea Bulk Drug Market Size, 2019-2021 (US$ Million) & (K MT)
Table 53. India Bulk Drug Market Size, 2019-2021 (US$ Million) & (K MT)
Table 54. ASEAN Bulk Drug Market Size, 2019-2021 (US$ Million) & (K MT)
Table 55. Latin America Bulk Drug Market Size, 2019-2021 (US$ Million) & (K MT)
Table 56. Middle East and Africa Bulk Drug Market Size, 2019-2021 (US$ Million) & (K MT)
Table 57. Teva Business Overview
Table 58. Teva Bulk Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Teva Bulk Drug Product
Table 60. Teva Response to COVID-19 and Related Developments
Table 61. Novartis Business Overview
Table 62. Novartis Bulk Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Novartis Bulk Drug Product
Table 64. Novartis Response to COVID-19 and Related Developments
Table 65. Pfizer Business Overview
Table 66. Pfizer Bulk Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Pfizer Bulk Drug Product
Table 68. Pfizer Response to COVID-19 and Related Developments
Table 69. Johnson & Johnson Business Overview
Table 70. Johnson & Johnson Bulk Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Johnson & Johnson Bulk Drug Product
Table 72. Johnson & Johnson Response to COVID-19 and Related Developments
Table 73. Mylan Business Overview
Table 74. Mylan Bulk Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Mylan Bulk Drug Product
Table 76. Mylan Response to COVID-19 and Related Developments
Table 77. North China Pharmaceutical Group Business Overview
Table 78. North China Pharmaceutical Group Bulk Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. North China Pharmaceutical Group Bulk Drug Product
Table 80. North China Pharmaceutical Group Response to COVID-19 and Related Developments
Table 81. Dr. Reddy’s Laboratories Business Overview
Table 82. Dr. Reddy’s Laboratories Bulk Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Dr. Reddy’s Laboratories Bulk Drug Product
Table 84. Dr. Reddy’s Laboratories Response to COVID-19 and Related Developments
Table 85. Roche Business Overview
Table 86. Roche Bulk Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Roche Bulk Drug Product
Table 88. Roche Response to COVID-19 and Related Developments
Table 89. Aurobindo pharma Business Overview
Table 90. Aurobindo pharma Bulk Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. Aurobindo pharma Bulk Drug Product
Table 92. Aurobindo pharma Response to COVID-19 and Related Developments
Table 93. Sun Pharmaceutical Industries Business Overview
Table 94. Sun Pharmaceutical Industries Bulk Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 95. Sun Pharmaceutical Industries Bulk Drug Product
Table 96. Sun Pharmaceutical Industries Response to COVID-19 and Related Developments
Table 97. Boehringer Ingelheim GmbH Business Overview
Table 98. Boehringer Ingelheim GmbH Bulk Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 99. Boehringer Ingelheim GmbH Bulk Drug Product
Table 100. Boehringer Ingelheim GmbH Response to COVID-19 and Related Developments
Table 101. Bayer Business Overview
Table 102. Bayer Bulk Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 103. Bayer Bulk Drug Product
Table 104. Bayer Response to COVID-19 and Related Developments
Table 105. BASF Business Overview
Table 106. BASF Bulk Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 107. BASF Bulk Drug Product
Table 108. BASF Response to COVID-19 and Related Developments
Table 109. DSM Business Overview
Table 110. DSM Bulk Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 111. DSM Bulk Drug Product
Table 112. DSM Response to COVID-19 and Related Developments
Table 113. Zhejiang Medicine Business Overview
Table 114. Zhejiang Medicine Bulk Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 115. Zhejiang Medicine Bulk Drug Product
Table 116. Zhejiang Medicine Response to COVID-19 and Related Developments
Table 117. Biocon Business Overview
Table 118. Biocon Bulk Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 119. Biocon Bulk Drug Product
Table 120. Biocon Response to COVID-19 and Related Developments
Table 121. Johnson Matthey Business Overview
Table 122. Johnson Matthey Bulk Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 123. Johnson Matthey Bulk Drug Product
Table 124. Johnson Matthey Response to COVID-19 and Related Developments
Table 125. Hisun Pharmacy Business Overview
Table 126. Hisun Pharmacy Bulk Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 127. Hisun Pharmacy Bulk Drug Product
Table 128. Hisun Pharmacy Response to COVID-19 and Related Developments
Table 129. Cambrex Business Overview
Table 130. Cambrex Bulk Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 131. Cambrex Bulk Drug Product
Table 132. Cambrex Response to COVID-19 and Related Developments
Table 133. Shandong Xinhua Pharmaceutical Business Overview
Table 134. Shandong Xinhua Pharmaceutical Bulk Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 135. Shandong Xinhua Pharmaceutical Bulk Drug Product
Table 136. Shandong Xinhua Pharmaceutical Response to COVID-19 and Related Developments
Table 137. Lonza group Business Overview
Table 138. Lonza group Bulk Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 139. Lonza group Bulk Drug Product
Table 140. Lonza group Response to COVID-19 and Related Developments
Table 141. Huahai Pharmaceutical Business Overview
Table 142. Huahai Pharmaceutical Bulk Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 143. Huahai Pharmaceutical Bulk Drug Product
Table 144. Huahai Pharmaceutical Response to COVID-19 and Related Developments
Table 145. Haerbin Pharmaceutical Group Business Overview
Table 146. Haerbin Pharmaceutical Group Bulk Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 147. Haerbin Pharmaceutical Group Bulk Drug Product
Table 148. Haerbin Pharmaceutical Group Response to COVID-19 and Related Developments
Table 149. Bulk Drug Distributors List
Table 150. Bulk Drug Customers List
Table 151. Covid-19 Impact on Bulk Drug Customers
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Bulk Drug Assessment
Table 9. COVID-19 Impact: Bulk Drug Market Trends
Table 10. COVID-19 Impact Global Bulk Drug Market Size
Table 11. Global Bulk Drug Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (K MT)
Table 12. Global Bulk Drug Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/MT)
Table 13. Global Bulk Drug Quarterly Market Size, 2020 (US$ Million) & (K MT)
Table 14. Global Bulk Drug Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 15. Global Bulk Drug Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (K MT)
Table 16. Global Bulk Drug Market Growth Drivers
Table 17. Global Bulk Drug Market Restraints
Table 18. Global Bulk Drug Market Opportunities
Table 19. Global Bulk Drug Market Challenges
Table 20. Key Manufacturers Bulk Drug Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 21. Top Manufacturers, Bulk Drug Market Size, 2019 (K MT) & (US$ Million)
Table 22. Bulk Drug Factory Price by Manufacturers 2020 (USD/MT)
Table 23. Location of Key Manufacturers Bulk Drug Manufacturing Plants
Table 24. Key Manufacturers Bulk Drug Market Served
Table 25. Date of Key Manufacturers Enter into Bulk Drug Market
Table 26. Key Manufacturers Bulk Drug Product Type
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Bulk Drug Market Size by Type, 2020, (US$ Million)
Table 29. Global Bulk Drug Market Size by Type, 2020 (K MT)
Table 30. Global Bulk Drug Price: by Type, 2020-2021 (USD/MT)
Table 31. Global Bulk Drug Market Size by Application: 2020-2021 (US$ Million)
Table 32. Global Bulk Drug Market Size by Application, 2020-2021 (K MT)
Table 33. Global Bulk Drug Price: by Application, 2020-2021 (USD/MT)
Table 34. Global Bulk Drug Market Size by Region, 2019-2021 (US$ Million)
Table 35. Global Bulk Drug Market Size by Region, 2019-2021 (K MT)
Table 36. By Country, North America Bulk Drug Market Size, 2019-2021 (US$ Million)
Table 37. By Country, North America Bulk Drug Market Size, 2019-2021 (K MT)
Table 38. US Bulk Drug Market Size, 2019-2021 (US$ Million) & (K MT)
Table 39. Canada Bulk Drug Market Size, 2019-2021 (US$ Million) & (K MT)
Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 41. By Country, Europe Bulk Drug Market Size, 2019-2021 (US$ Million)
Table 42. By Country, Europe Bulk Drug Market Size, 2019-2021 (K MT)
Table 43. Germany Bulk Drug Market Size, 2019-2021 (US$ Million) & (K MT)
Table 44. France Bulk Drug Market Size, 2019-2021 (US$ Million) & (K MT)
Table 45. UK Bulk Drug Market Size, 2019-2021 (US$ Million) & (K MT)
Table 46. Italy Bulk Drug Market Size, 2019-2021 (US$ Million) & (K MT)
Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 48. By Region, Asia-Pacific Bulk Drug Market Size, 2019-2021 (US$ Million)
Table 49. By Region, Asia-Pacific Bulk Drug Market Size, 2019-2021 (K MT)
Table 50. China Bulk Drug Market Size, 2019-2021 (US$ Million) & (K MT)
Table 51. Japan Bulk Drug Market Size, 2019-2021 (US$ Million) & (K MT)
Table 52. South Korea Bulk Drug Market Size, 2019-2021 (US$ Million) & (K MT)
Table 53. India Bulk Drug Market Size, 2019-2021 (US$ Million) & (K MT)
Table 54. ASEAN Bulk Drug Market Size, 2019-2021 (US$ Million) & (K MT)
Table 55. Latin America Bulk Drug Market Size, 2019-2021 (US$ Million) & (K MT)
Table 56. Middle East and Africa Bulk Drug Market Size, 2019-2021 (US$ Million) & (K MT)
Table 57. Teva Business Overview
Table 58. Teva Bulk Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Teva Bulk Drug Product
Table 60. Teva Response to COVID-19 and Related Developments
Table 61. Novartis Business Overview
Table 62. Novartis Bulk Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Novartis Bulk Drug Product
Table 64. Novartis Response to COVID-19 and Related Developments
Table 65. Pfizer Business Overview
Table 66. Pfizer Bulk Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Pfizer Bulk Drug Product
Table 68. Pfizer Response to COVID-19 and Related Developments
Table 69. Johnson & Johnson Business Overview
Table 70. Johnson & Johnson Bulk Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Johnson & Johnson Bulk Drug Product
Table 72. Johnson & Johnson Response to COVID-19 and Related Developments
Table 73. Mylan Business Overview
Table 74. Mylan Bulk Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Mylan Bulk Drug Product
Table 76. Mylan Response to COVID-19 and Related Developments
Table 77. North China Pharmaceutical Group Business Overview
Table 78. North China Pharmaceutical Group Bulk Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. North China Pharmaceutical Group Bulk Drug Product
Table 80. North China Pharmaceutical Group Response to COVID-19 and Related Developments
Table 81. Dr. Reddy’s Laboratories Business Overview
Table 82. Dr. Reddy’s Laboratories Bulk Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Dr. Reddy’s Laboratories Bulk Drug Product
Table 84. Dr. Reddy’s Laboratories Response to COVID-19 and Related Developments
Table 85. Roche Business Overview
Table 86. Roche Bulk Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Roche Bulk Drug Product
Table 88. Roche Response to COVID-19 and Related Developments
Table 89. Aurobindo pharma Business Overview
Table 90. Aurobindo pharma Bulk Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. Aurobindo pharma Bulk Drug Product
Table 92. Aurobindo pharma Response to COVID-19 and Related Developments
Table 93. Sun Pharmaceutical Industries Business Overview
Table 94. Sun Pharmaceutical Industries Bulk Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 95. Sun Pharmaceutical Industries Bulk Drug Product
Table 96. Sun Pharmaceutical Industries Response to COVID-19 and Related Developments
Table 97. Boehringer Ingelheim GmbH Business Overview
Table 98. Boehringer Ingelheim GmbH Bulk Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 99. Boehringer Ingelheim GmbH Bulk Drug Product
Table 100. Boehringer Ingelheim GmbH Response to COVID-19 and Related Developments
Table 101. Bayer Business Overview
Table 102. Bayer Bulk Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 103. Bayer Bulk Drug Product
Table 104. Bayer Response to COVID-19 and Related Developments
Table 105. BASF Business Overview
Table 106. BASF Bulk Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 107. BASF Bulk Drug Product
Table 108. BASF Response to COVID-19 and Related Developments
Table 109. DSM Business Overview
Table 110. DSM Bulk Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 111. DSM Bulk Drug Product
Table 112. DSM Response to COVID-19 and Related Developments
Table 113. Zhejiang Medicine Business Overview
Table 114. Zhejiang Medicine Bulk Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 115. Zhejiang Medicine Bulk Drug Product
Table 116. Zhejiang Medicine Response to COVID-19 and Related Developments
Table 117. Biocon Business Overview
Table 118. Biocon Bulk Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 119. Biocon Bulk Drug Product
Table 120. Biocon Response to COVID-19 and Related Developments
Table 121. Johnson Matthey Business Overview
Table 122. Johnson Matthey Bulk Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 123. Johnson Matthey Bulk Drug Product
Table 124. Johnson Matthey Response to COVID-19 and Related Developments
Table 125. Hisun Pharmacy Business Overview
Table 126. Hisun Pharmacy Bulk Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 127. Hisun Pharmacy Bulk Drug Product
Table 128. Hisun Pharmacy Response to COVID-19 and Related Developments
Table 129. Cambrex Business Overview
Table 130. Cambrex Bulk Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 131. Cambrex Bulk Drug Product
Table 132. Cambrex Response to COVID-19 and Related Developments
Table 133. Shandong Xinhua Pharmaceutical Business Overview
Table 134. Shandong Xinhua Pharmaceutical Bulk Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 135. Shandong Xinhua Pharmaceutical Bulk Drug Product
Table 136. Shandong Xinhua Pharmaceutical Response to COVID-19 and Related Developments
Table 137. Lonza group Business Overview
Table 138. Lonza group Bulk Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 139. Lonza group Bulk Drug Product
Table 140. Lonza group Response to COVID-19 and Related Developments
Table 141. Huahai Pharmaceutical Business Overview
Table 142. Huahai Pharmaceutical Bulk Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 143. Huahai Pharmaceutical Bulk Drug Product
Table 144. Huahai Pharmaceutical Response to COVID-19 and Related Developments
Table 145. Haerbin Pharmaceutical Group Business Overview
Table 146. Haerbin Pharmaceutical Group Bulk Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 147. Haerbin Pharmaceutical Group Bulk Drug Product
Table 148. Haerbin Pharmaceutical Group Response to COVID-19 and Related Developments
Table 149. Bulk Drug Distributors List
Table 150. Bulk Drug Customers List
Table 151. Covid-19 Impact on Bulk Drug Customers
LIST OF FIGURES
Figure 1. Bulk Drug Product Picture
Figure 2. Bulk Drug Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Bulk Drug Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Bulk Drug Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Bulk Drug Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Bulk Drug Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Bulk Drug Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Bulk Drug Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Bulk Drug Market Size Market Share, 2019-2021
Figure 1. Bulk Drug Product Picture
Figure 2. Bulk Drug Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Bulk Drug Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Bulk Drug Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Bulk Drug Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Bulk Drug Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Bulk Drug Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Bulk Drug Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Bulk Drug Market Size Market Share, 2019-2021
